HaNDL syndrome after "benign" OKT3-induced meningitis.
Thomas
M C
MC
Walker
R
R
Wright
A
A
D000328:Adult; D006084:Graft Rejection / Q000517:prevention & control; D006261:Headache / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D008218:Lymphocytosis / Q000134:cerebrospinal fluid; D008297:Male; D008582:Meningitis, Aseptic / Q000150:complications* / Q000276:immunology; D016853:Muromonab-CD3 / Q000009:adverse effects* / Q000627:therapeutic use; D009422:Nervous System Diseases; D013577:Syndrome
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3